医学
怀孕
甲状腺
甲状腺炎
甲状腺疾病
内分泌系统
疾病
儿科
产科
妇科
重症监护医学
内科学
激素
生物
遗传学
作者
Rajesh Rajput,Sarita Bajaj,Sujoy Ghosh,Pramila Kalra,Arun S. Menon,Minni G. Pillai,Prasanna Kumar,Shashank Joshi,Krishna Seshadri,R. Jayakumar,Mohd Ashraf Ganie,Jabbar Puttiyaveettil,Sushil Gupta,Hema Girish Rao
出处
期刊:Thyroid Research and Practice
日期:2021-09-01
卷期号:18 (3): 89-110
被引量:6
标识
DOI:10.4103/trp.trp_17_22
摘要
Thyroid disease is the second most common endocrine disorder encountered in pregnant women with substantial maternal and fetal implications. Therefore, assessing thyroid status during pregnancy is essential for initiating treatment in newly diagnosed individuals and adjusting doses for those already under treatment. To initiate proper and timely treatment evidence-based recommendations are required for clinical decision-making in managing thyroid disorders in pregnant and postpartum women. Keeping this in mind, task force consisted of experts in the fields of endocrinology and thyroid disease was constituted and various published data and guidelines were explored to address screening, diagnosis, and management of hypothyroidism, thyrotoxicosis, GD, thyroid nodules, and post-partum thyroiditis and their related complications during pregnancy. This document provides much-required insights and useful, practical, and accurate guidance that aids a practicing clinician.
科研通智能强力驱动
Strongly Powered by AbleSci AI